Prognostic value of high IMP3 expression in solid tumors: a meta-analysis

References

• Mueller-PillaschFPohlBWildaMExpression of the highly conserved RNA binding protein KOC in embryogenesisMech Dev1999881959910525192
   PubMedGoogle Scholar
• LiaoBHuYHerrickDJBrewerGThe RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cellsJ Biol Chem200528018185171852415753088
   PubMedGoogle Scholar
• LiWLiuDChangWRole of IGF2BP3 in trophoblast cell invasion and migrationCell Death Dis20145e102524457969
   PubMedGoogle Scholar
• JønsonLChristiansenJHansenTVVikesåJYamamotoYNielsenFCIMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and developmentCell Rep20147253955124703842
   PubMed Web of Science ®Google Scholar
• SamantaSSharmaVMKhanAMercurioAMRegulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancerOncogene201231444689469722266872
   PubMedGoogle Scholar
• LedererMBleyNSchleiferCHuttelmaierSThe role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancerSemin Cancer Biol20142931225068994
   PubMed Web of Science ®Google Scholar
• GongYWodaBAJiangZOncofetal protein IMP3, a new cancer biomarkerAdv Anat Pathol201421319120024713990
   PubMed Web of Science ®Google Scholar
• JiangZChuPGWodaBAAnalysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective studyLancet Oncol20067755656416814207
   PubMed Web of Science ®Google Scholar
• YanJWeiQJianWIMP3 predicts invasion and prognosis in human lung adenocarcinomaLung2016194113714626608347
   PubMedGoogle Scholar
• KimKYChaIHRisk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarkerJ Cancer Res Clin Oncol2012138348349022193423
   PubMedGoogle Scholar
• OkadaKFujiwaraYNakamuraYOncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinomaJ Surg Oncol2012105878078522012575
   PubMedGoogle Scholar
• LochheadPImamuraYMorikawaTInsulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancerEur J Cancer201248183405341322840368
   PubMed Web of Science ®Google Scholar
• WeiQYanJFuBIMP3 expression is associated with poor survival in cervical squamous cell carcinomaHum Pathol201445112218222425176620
   PubMedGoogle Scholar
• ChromeckiTFChaEKPummerKPrognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomyBJU Int20121101636822077633
   PubMed Web of Science ®Google Scholar
• IkenbergKFritzscheFRZuerrer-HaerdiUInsulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scoresBMC Cancer20101034120591150
   PubMedGoogle Scholar
• KobelMXuHBournePAIGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtypeMod Pathol200922346947519136932
   PubMedGoogle Scholar
• NoskeAFaggadAWirtzRIMP3 expression in human ovarian cancer is associated with improved survivalInt J Gynecol Pathol200928320321019620937
   PubMedGoogle Scholar
• MoherDLiberatiATetzlaffJAltmanDGGroupPPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementInt J Surg20108533634120171303
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• DarrochJNThe Mantel-Haenszel test and tests of marginal symmetry; fixed-effects and mixed models for a categorical response, correspondent paperInt Stat Rev1981493285307
   Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• HoffmannNESheininYLohseCMExternal validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinomaCancer200811271471147918260086
   PubMed Web of Science ®Google Scholar
• PeiXLiMZhanJEnhanced IMP3 expression activates NF-small ka, CyrillicB pathway and promotes renal cell carcinoma progressionPLoS One2015104e012433825919292
   PubMedGoogle Scholar
• ParkJYChoeMKangYLeeSSIMP3, a promising prognostic marker in clear cell renal cell carcinomaKorean J Pathol201448210811624868223
   PubMedGoogle Scholar
• JiangZLohseCMChuPGOncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomasCancer2008112122676268218412154
   PubMedGoogle Scholar
• TantravahiSKAlbertsonDAgarwalAMSurvival outcomes and tumor IMP3 expression in patients with sarcomatoid metastatic renal cell carcinomaJ Oncol2015201518192625688268
   PubMedGoogle Scholar
• LinLZhangJWangYExpression of insulin-like growth factor 2 mRNA-binding protein 3 expression and analysis of prognosis in the patients with lung squamous cell carcinomaXi Bao Yu Fen Zi Mian Yi Xue Za Zhi201329769469723837977
   PubMedGoogle Scholar
• Beljan PerakRDurdovMGCapkunVIMP3 can predict aggressive behaviour of lung adenocarcinomaDiagn Pathol2012716523190601
   PubMedGoogle Scholar
• SunXWeiPShenCPrognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese casesAm J Cancer Res2015572266227626328257
   PubMedGoogle Scholar
• ZhangJOuYMaYClinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinomaOncol Lett2015941927193325789070
   PubMedGoogle Scholar
• Del GobboAVairaVGuerini RoccoEThe oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lungJ Thorac Oncol20149111656166125144243
   PubMedGoogle Scholar
• ClauditzTSWangCJGontarewiczAExpression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neckJ Oral Pathol Med201342212513222643116
   PubMed Web of Science ®Google Scholar
• LiSChaJKimJInsulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinomaHead Neck201133336837420652886
   PubMedGoogle Scholar
• LinCYChenSTJengYMInsulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinomaJ Oral Pathol Med201140969970523647076
   PubMedGoogle Scholar
• NiedworokCPanitzMSzarvasTUrachal carcinoma of the bladder: impact of clinical and immunohistochemical parameters on prognosisJ Urol201619561690169626678957
   PubMedGoogle Scholar
• SitnikovaLMendeseGLiuQIMP3 predicts aggressive superficial urothelial carcinoma of the bladderClin Cancer Res20081461701170618347170
   PubMedGoogle Scholar
• SzarvasTvom DorpFNiedworokCHigh insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancerBJU Int20121106 pt BE308E31722500655
   PubMedGoogle Scholar
• LeeDJXylinasERiekenMInsulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinomaEur Urol201466237938524388440
   PubMedGoogle Scholar
• HsuKFShenMRHuangYFOverexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancerBr J Cancer2015113341442426158423
   PubMed Web of Science ®Google Scholar
• BiRShenXZhangWClear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expressionDiagn Pathol2016111726837693
   PubMedGoogle Scholar
• HuSWuXZhouBIMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinomaJ Cancer Res Clin Oncol2014140688389324647926
   PubMedGoogle Scholar
• WachterDLKristiansenGSollCInsulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic valueHistopathology201260227828622211286
   PubMedGoogle Scholar
• ChenLTLinLJZhengLLThe correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosisHepatogastroenterology20136012355355623159356
   PubMedGoogle Scholar
• LinLZhangJWangYInsulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinomaOncol Lett20136374074424137402
   PubMedGoogle Scholar
• YuanRHWangCCChouCCChangKJLeePHJengYMDiffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinomaAnn Surg Oncol20091661711171919357927
   PubMedGoogle Scholar
• LiDYanDTangHIMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesisAnn Surg Oncol200916123499350619672661
   PubMed Web of Science ®Google Scholar
• SzarvasTTschirdewahnSNiedworokCPrognostic value of tissue and circulating levels of IMP3 in prostate cancerInt J Cancer201413571596160424615121
   PubMed Web of Science ®Google Scholar
• SchaefferDFOwenDRLimHJInsulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survivalBMC Cancer2010105920178612
   PubMedGoogle Scholar
• WangBJWangLYangSYLiuZJExpression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesionsClin Transl Oncol201517321522225183049
   PubMedGoogle Scholar
• MorimatsuKAishimaSYamamotoHInsulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasmHum Pathol20134491714172123597774
   PubMedGoogle Scholar
• WangLLiHGXiaZSLuJPengTSIMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective studyChin Med J (Engl)2010123243554355822166630
   PubMedGoogle Scholar
• ChenYLJengYMHsuHCExpression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinomaInt J Surg2013111859123246869
   PubMedGoogle Scholar
• GaoYYangMJiangZIMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinomaHum Pathol20144561184119124745619
   PubMed Web of Science ®Google Scholar
• LiHGHanJJHuangZQWangLChenWLShenXMIMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinomaJ Craniofac Surg20112262022202522067851
   PubMedGoogle Scholar
• AsioliSEricksonLARighiAPoorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expressionMod Pathol20102391269127820562850
   PubMedGoogle Scholar
• ZhouMChenKYangHExpression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordomaJ Neurooncol20141161778224135846
   PubMedGoogle Scholar
• BartonVNDonsonAMBirksDKInsulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytomaJ Neuropathol Exp Neurol201372544244923584203
   PubMedGoogle Scholar
• ChenSTJengYMChangCCInsulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastomaCancer Sci2011102122191219821917080
   PubMedGoogle Scholar
• HaoSSmithTWChuPGThe oncofetal protein IMP3: a novel molecular marker to predict aggressive meningiomaArch Pathol Lab Med201113581032103621809995
   PubMedGoogle Scholar
• SheenYSLiaoYHLinMHIMP-3 promotes migration and invasion of melanoma cells by modulating the expression of HMGA2 and predicts poor prognosis in melanomaJ Invest Dermatol201513541065107325380351
   PubMedGoogle Scholar
• WalterOPrasadMLuSQuinlanRMEdmistonKLKhanAIMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotypeHum Pathol200940111528153319695680
   PubMedGoogle Scholar
• ZhangKZhouMChenHWuGChenKYangHExpression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesisClin Transl Oncol201517757057525740666
   PubMedGoogle Scholar
• RienerMOFritzscheFRClavienPAIMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomasHum Pathol200940101377138319467694
   PubMedGoogle Scholar
• TakataATakiguchiSOkadaKExpression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinomaOncol Lett2014852027203125295085
   PubMedGoogle Scholar
• Rivera VargasTBoudoukhaSSimonAPost-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localizationOncogene201433222866287523812426
   PubMedGoogle Scholar
• SuPHuJZhangHIMP3 expression is associated with epithelial-mesenchymal transition in breast cancerInt J Clin Exp Pathol2014763008301725031719
   PubMedGoogle Scholar